PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: air traffic controller

UK Public Assessment Report

UKPAR Chlorhexidine Gluconate 2% w/v Impregnated Pad PL 27821/0004 1 Chlorhexidine Gluconate 2% w/v Impregnated Pad (chlorhexidine gluconate) PL 27821/0004 UK Public Assessment Report TABLE OF CONTENTS Lay Summary Page 2 Scientific discussion Page 3 Steps taken for Assessment Page 20 Steps taken after authorisation Page 21 Summary of Product Characteristics Page 22 Product Information Leaflet Page 26 Labelling Page 28 UKPAR Chlorhexidine Gluconate 2% w/v Impregnated Pad PL 27821/0004 2 Chlorhexidine Gluconate 2% w/v Impregnated Pad PL 27821/0004 LAY SUMMARY The Medicines and Healthcare products Regulatory Agency (MHRA) granted Baggerman FarmaNet NV a Marketing Authorisation (licence) for the medicinal product Chlorhexidine Gluconate 2% w/v Impregnated Pad (PL 27821/0004) on 7th July 2010.

UKPAR Chlorhexidine Gluconate 2% w/v Impregnated Pad PL 27821/0004 5 PHARMACEUTICAL ASSESSMENT ACTIVE SUBSTANCE …

Fullscreen Download
Loading..

Tags:

  Assessment, Pharmaceutical, Active, Public, Uk public assessment

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of UK Public Assessment Report

Documents from same domain

Cefixime 400 mg Film-coated Tablets, PL 22805 …

www.mhra.gov.uk

MHRA PAR; CEFIXIME 400 MG FILM-COATED TABLETS, PL 22805/0032-3 2 Lay summary The Medicines and Healthcare products Regulatory Agency …

  Cefixime

The Human Medicines Regulations 2012 – …

www.mhra.gov.uk

The Human Medicines Regulations 2012 – description of each Part This document provides a brief overview of each Part of the Human Medicines Regulations 2012 …

  Human, Regulations, Descriptions, Medicine, 2012, Human medicines regulations 2012, Human medicines regulations 2012 description of

FULTIUM -D 800 IU CAPSULES - GOV.UK

www.mhra.gov.uk

Vitamin D deficiency, with levels of 25(OH)D below 25nmol/L (10ng/ml), could result in the disease rickets (or osteomalacia). The disease resulting as a deficiency is considered to be due to malabsorption

  Deficiency, Capsule, Vitamin, Fultium d 800 iu capsules, Fultium, Vitamin d deficiency

GLYCOPYRRONIUM BROMIDE 0.2MG/ML …

www.mhra.gov.uk

UKPAR Glycopyrronium Bromide 0.2 mg/ml Solution for Injection PL 00156/0115 1 GLYCOPYRRONIUM BROMIDE 0.2MG/ML SOLUTION FOR INJECTION (PL 00156/0115)

  Solutions, Injection, 0115, Solution for injection pl 00156, 00156, Solution for injection, Pl 00156

Meloxicam - GOV.UK

www.mhra.gov.uk

PL 31388/0003-4 UKPAR Alpex Pharma (UK) Ltd, Meloxicam 7.5mg and 15mg Orodispersible Tablets 3 Scientific Discussion INTRODUCTION Based on the review of the data on quality, safety and efficacy, the UK granted

  15mg, Meloxicam

PL 00010/0643 - GOV.UK

www.mhra.gov.uk

UKPAR Canesten HC Cream PL 00010/0643 6 All excipients comply with their respective European Pharmacopoeia monographs, except triceteareth-4-

  Excipients, 3460, Pl 00010 0643, 00010

Public Assessment Report UKPAR Canesten Combi …

www.mhra.gov.uk

This is a summary of the Public Assessment Report (PAR) for Canesten Combi Pessary & External Cream 500mg / 2% w/w pessary & cream (PL 00010/0653).

DCPAR for Ampicillin-Salbactam 1 g--0 5 and 2 g-1 g ...

www.mhra.gov.uk

PAR Ampicillin/Sulbactam 1 g/0.5 g and 2 g/1 g powder for Solution for Injection or Infusion UK/H/4322/001-2/DC 1 Public Assessment Report Decentralised Procedure

  Solutions

Public Assessment Report Mutual Recognition …

www.mhra.gov.uk

PAR Sayana 104mg/0.65ml Suspension for Injection UK/H/0960/001/MR 1 Public Assessment Report Mutual Recognition Procedure SAYANA 104MG/0.65ML SUSPENSION FOR INJECTION

  Assessment, Report, Public, Procedures, Mutual, Recognition, Public assessment report mutual recognition, Public assessment report mutual recognition procedure

Public Assessment Report Decentralised Procedure …

www.mhra.gov.uk

Public Assessment Report Decentralised Procedure LIOTHYRONINE SODIUM 20 MICROGRAM TABLETS (liothyronine sodium) Procedure No: UK/H/6516/001/DC

  Assessment, Report, Public, Procedures, Public assessment report decentralised procedure, Decentralised

Related documents

STABILITY TESTING OF ACTIVE PHARMACEUTICAL …

www.who.int

Working document QAS/17.694 January 2017 Draft document for comment 1 STABILITY TESTING OF ACTIVE 2 PHARMACEUTICAL INGREDIENTS AND 3 FINISHED PHARMACEUTICAL PRODUCTS ...

  Product, Pharmaceutical, Active, Ingredients, Active pharmaceutical, Pharmaceutical ingredients and, Finished pharmaceutical products, Finished

Annexure-1 GMP CHECKLIST

cdsco.nic.in

SOP No.: EP-INS-004 Page 1 Annexure-1 GMP CHECKLIST (Based on WHO Good Manufacturing Practices (GMP) for active pharmaceutical ingredients stated as per

  Pharmaceutical, Annexure 1 gmp checklist, Annexure, Checklist, Active, Ingredients, Active pharmaceutical ingredients

ACTIVE PHARMACEUTICAL INGREDIENTS - Malladi

www.malladi.co.in

ACTIVE PHARMACEUTICAL INGREDIENTS CNS Methylphenidate HCl Alprazolam + Lorazepam + ANTI PARKINSON Selegiline HCl Rasagiline Mesylate CVS S-Amlodipine

  Pharmaceutical, Active, Ingredients, Active pharmaceutical ingredients

DEFINITION OF ACTIVE PHARMACEUTICAL …

www.who.int

working document qas/11.426/rev.1 july 2011 restricted definition of active pharmaceutical ingredient revised draft for comment

  Pharmaceutical, Active, Ingredients, Active pharmaceutical ingredients, Active pharmaceutical

The Regulation of Cosmetics in Japan

www.yakujihou.com

[Fig. 12] A list of 30 prohibited ingredients 1 6-Acetoxy-2,4-dimethyl-m-dioxane 2 Antihistamines except those of aminoether type (such as diphenhydramine) 3 Hormones and those derivatives except ...

  Ingredients, Regulations, Lists, Cosmetic, Japan, The regulation of cosmetics in japan

cosmetics - Kraeber & Co GmbH

www.kraeber.de

Kraeber offers cosmetic and pharmaceutical substances since 1980. The company was founded by Jens Uwe Kraeber, JUK, who is still not retired and assists

  Pharmaceutical

Related search queries

ACTIVE PHARMACEUTICAL, ACTIVE, PHARMACEUTICAL INGREDIENTS AND, FINISHED PHARMACEUTICAL PRODUCTS, Annexure-1 GMP CHECKLIST, ACTIVE PHARMACEUTICAL INGREDIENTS, Active pharmaceutical ingredient, The Regulation of Cosmetics in Japan, List, Ingredients, Pharmaceutical